Back to Trades
Chevallard Daniel R.
Chief Financial OfficerCIK 0001706176
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 3 filings between 2026, Chevallard Daniel R., Chief Financial Officer, has disclosed $3.4M in transactions — all concentrated in LENZ Therapeutics, Inc. (LENZ). Their disclosed trades are heavily weighted toward buying — $64.3K in buys and $0 in sells. The largest single open-market purchase on record is $64.3K in LENZ Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Nov 3 | LENZ LENZ Therapeutics, Inc. | Chevallard Daniel R. | Chief Financial Officer | Award | $2.0M |
| Mar 30 | LENZ LENZ Therapeutics, Inc. | Chevallard Daniel R. | Chief Financial Officer | Buy | $64.3K |
| Jan 6 | LENZ LENZ Therapeutics, Inc. | Chevallard Daniel R. | Chief Financial Officer | Award | $1.3M |
3 filings